Aspire Biopharma Holdings, Inc. (ASBP)

NASDAQ: ASBP · Real-Time Price · USD

0.3300

-0.0265 (-7.43%)

At close: May 12, 2025, 4:00 PM

0.3470

+0.0170 (5.15%)

After-hours: May 12, 2025, 7:47 PM EDT

Aspire Biopharma Holdings Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022
Period Ending	Sep '24 Sep 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Selling, General & Admin	0.61	0.29	0.42
Research & Development	0.04	0.07	0.18
Operating Expenses	0.65	0.36	0.6
Operating Income	-0.65	-0.36	-0.6
Pretax Income	-0.65	-0.36	-0.6
Income Tax Expense	0	0	0
Net Income	-0.65	-0.36	-0.6
Net Income to Common	-0.65	-0.36	-0.6
Shares Outstanding (Basic)	443	443	-
Shares Outstanding (Diluted)	443	443	-
EPS (Basic)	-0.00	-0.00	-
EPS (Diluted)	-0.00	-0.00	-
EBIT	-0.65	-0.36	-0.6

Updated Jan 8, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.